Obesity is a significant risk factor for the development of cardiovascular disease as it often 105 appears clinically with other risk factors such as diabetes, hypertension, and hyperlipidemia 106 giving rise to the metabolic syndrome. Another common cardiovascular risk factor associated 107 with obesity is impaired vascular relaxation. Studies in animal models of obesity have 108 documented that obesity is associated with impaired vascular relaxation (13; 24; 29; 39; 42). 109
Similar observations have also been made in human patient populations (5; 58). While impaired 110 vascular relaxation has been widely documented in obesity, the underlying cause responsible for 111 this phenotype has yet to be established. 112
113
One potential candidate for mediating the altered vascular relaxation in obesity is leptin. Leptin 114 is a hormone produced from white adipocytes which acts on its receptors in the hypothalamus to 115 control food intake and energy expenditure. Mutations in leptin and its receptor cause genetic 116 obesity in rodents and humans (30; 40; 46; 62; 64). While leptin receptors are highly expressed 117 in the brain and nervous system, they are also present in the periphery including the vasculature. 118
Leptin receptors are expressed in both endothelial and vascular smooth muscle (VSM) cells (54) . 119
Interestingly, in obesity, plasma leptin levels are very high suggesting a central resistance to the 120 effects of leptin on appetite and energy expenditure; however, the peripheral actions are believed 121 to remain intact (15; 35). 122
123
Leptin has been reported to have several conflicting effects on the vasculature. Leptin has been 124 found to both promote and inhibit VSM cell growth and proliferation (8; 22; 32; 44; 51; 56; 63). 125
Studies in both animal models as well as human patient populations have linked leptin to theResubmission Feb23, 2016 5 development and progression of atherosclerosis (7; 36; 50; 57). Leptin also has confounding 127 effects on vascular resistance. It can promote the release of the potent vasoconstrictor, 128 endothelin, and increase the expression of its receptors in both endothelial and VSM cells (12; 129 23; 48). Leptin also increases the expression of renin-angiotensin system components 130 (angiotensinogen, angiotensin receptors) and it is well known that renin-angiotensin activation 131 has profound vascular effects (63). However, leptin also increases the levels and activity of both 132 endothelial and neuronal nitric oxide synthase to increase nitric oxide (NO) levels which is a 133 major vasodilator (4; 31; 51; 53; 59). Leptin signals via the long form of the leptin receptor 134 through activation of STAT3, Shp2, and PI3K/Akt pathways and acutely increases NO levels 135 through activation of the PI3K/Akt pathway (20; 59). However, prolonged exposure to leptin 136 has been reported to attenuate NO production and phosphorylation of NOS3 through up-137 regulation of SOCS3 expression (6). 138
139
While these diverse actions of leptin in the vasculature are established in the literature, the 140 specific effect of leptin's action in VSM cells has yet to be elucidated. We utilized a Cre-loxP 141 based approach to effectively knockout leptin receptors from VSM cells in order to determine the 142 effect of VSM cell leptin receptors on vascular reactivity. We utilized a mouse model in which 143 exon 1 of the leptin receptor gene was flanked by loxP sites to create a model with loss of all 144 leptin receptor splice variants in VSM cells in vivo (14; 27). We bred these floxed leptin 145 receptor mice to with a tamoxifen-inducible Cre recombinase expressed specifically in VSM 146 cells to test the hypothesis that VSM cell leptin receptors mediate the alterations in vascular 147 relaxation in response to high leptin levels typically observed in obesity. offspring were maintained on a C57BL/6 background as previously described (21). These mice 155 contain loxP sites which flank exon 1 of the leptin receptor gene (14). Since this exon contains 156 the signal sequence, Cre-mediated deletion of this exon results in the loss of all LR splice 157 variants (14). Vascular smooth muscle-specific inducible Cre mice (SM22-MerCreMer) were as 158 originally described (27). All mice were fed a standard diet containing 0.29% NaCl and 159 provided water ad libitum. Tamoxifen was administered via a specially prepared diet which was 160 identical in composition to the standard diet but contained tamoxifen at a concentration of 50 161 mg/kg (Harlan Laboratories, Inc., Madison, WI). Mice were fed the tamoxifen diet for a period 162 of 6 weeks after which time they were switched back to the standard diet. Experiments were then 163 performed 2 weeks after switching back to the standard diet. 
levels. 282
The levels of both total NOS3 and phospho Ser1177 NOS3 were determined by Western blot 283 using aortic lysates from control and VSM LepR KO mice. Total NOS3 levels did not differ in 284 the aorta between control and VSM LepR KO mice ( Figure 4A & B) . However, the levels of 285 phsopho Ser 1177 NOS3 were significantly diminished in the aorta VSM LepR KO as compared 286 to control mice ( Figure 4A & C) . 287 288 289
VSM deletion of leptin receptor decreases vascular NOX4 and SOD3 levels. 290
The effect of VSM deletion of the leptin receptor on enzymes involved in regulating the 291 production of vascular superoxide was determined by real-time PCR using RNA derived from 292 the aorta of control and VSM LepR KO mice. NADPH oxidases are a family of proteins 293 responsible for the generation of superoxide in the vasculature. NOX4, which is the major 294 isoform of NADPH oxidase present in the vasculature, was decreased by 90% in the aortas of 295 VSM LepR KO mice as compared to control mice ( Figure 5A ). This significant decrease in 296 vascular NOX4 expression was associated with a 2 fold induction of NOX1 expression in the 297 aorta of VSM LepR KO as compared to control mice ( Figure 5A ). VSM LepR KO mice also 298 exhibit a 90% decrease superoxide dismutase (SOD) 3 expression and a 20% increase in SOD2 299 expression in the aorta as compared to control mice ( Figure 5B) . 300 301
302
VSM deletion of leptin receptor has no effect on blood pressure or heart rate. 303 304
In order to determine the effect of loss of VSM leptin receptors on basal blood pressure, we 305 measured conscious 24-hour blood pressure in tamoxifen treated control and KO mice for 7 days 306 by radiotelemetry. Knockout of VSM leptin receptors did not have any effect on 24 hour mean 307 arterial pressure (MAP) or heart rate ( Figure 6A & B) . Additionally, no effect of VSM leptin 308 receptor knockout was observed on either daytime or nighttime MAP (Figure 6C & D) . In 309 addition, no differences in body weight, heart weight, heart weight to body weight ratio or heart 310 weight to body length ratio were found between control and KO mice (Table 1).  311   312  313  Discussion  314  315 Obesity is associated with an increased incidence of cardiovascular diseases. As it often appears 316 with other metabolic abnormalities such as diabetes, hyperlipidemia, hypercholesterolemia, andinflammation it is difficult to specifically determine the importance of obesity alone in the 318 development of cardiovascular disease such as hypertension and heart disease. One of the 319 potential links between obesity and the development of hypertension is the hormone, leptin, 320 which is released primarily from white adipose tissue and is elevated in obesity. Elevated leptin 321 levels as observed in obesity can directly cause hypertension through a central mechanism 322 resulting in increased sympathetic outflow to peripheral organs like the kidney (11; 41; 49; 55). 323
High plasma levels may also promote hypertension and cardiovascular disease through 324 impairment of vascular relaxation. In our study, we observed a significant effect of acute high 325 leptin levels similar to those observed in obese individuals to attenuate ACh mediated vascular 326 relaxation. This response was likely due in part to leptin mediated increases in VSM cell 327 oxidative stress as treatment with the anti-oxidant compound, tempol, significantly attenuated the 328 effect of high leptin levels on ACh mediated vascular relaxation. The effect of leptin to attenuate 329
ACh mediated relaxation was also a VSM cell dependent effect as deletion of leptin receptors 330 also prevented this response. The alterations in the ability of leptin to attenuate ACh-mediated 331 relaxation in VSM LepR KO mice was not due to alterations in vascular reactivity in these mice 332 as they exhibited normal responses to sodium nitroprusside and U46619. Previous studies have 333 reported that leptin can cause increases in the levels of oxidative stress in endothelial cells and 334 cardiomyocytes (9; 17). The mechanism by which leptin increases vascular oxidative stress is not 335 known but maybe mediated via stimulation of NAD(P)H oxidases (18). NOX4 and NOX1 are 336 thought to be the major isoforms of NAD(P)H oxidase in the vasculature responsible for 337 superoxide production (3; 33). VSM Lep R KO mice exhibited a greater than 90% decrease in 338 vascular expression of NOX4 as compared to control mice and an increase in vascular NOX1 339 expression. It is possible that the leptin receptor acting either directly or through increases inangiotensin II or endothelin is responsible for maintaining NOX4 expression levels in the 341 vasculature to increase NAD(P)H-mediated superoxide production (43; 60; 63). It is not known 342 if the observed increase in vascular NOX1 levels in the VSM LepR KO mice is a compensatory 343 response to loss of vascular NOX4; however, it is clear that the enhanced NOX1 expression is 344 not sufficient to mediate the effect of leptin to attenuate ACh mediated relaxation in the VSM 345 LepR KO mice. Superoxide dismutases (SODs) are a family of proteins which are responsible 346 for protecting the vasculature from reactive oxygen species (ROS) such as superoxide (37). We 347 
Perspectives and Significance 404
We developed a novel model of VSM cell specific knockout of leptin receptors to assess the 405 impact of high circulating levels of leptin on vascular function. We found that high leptin levels 406 attenuate ACh mediated vasorelaxation and this effect was reversed by pretreatment of vascular 407 segments with the antioxidant compound tempol. We further demonstrate that VSM cell specific 408 loss of leptin receptors attenuated the effect of leptin to inhibit ACh mediated vascular 409 relaxation. VSM deletion of the leptin receptor was associated with decreased aortic expression 410 of NOX4 and SOD3 and phosphorylation of NOS3 at Ser 1177. VSM cell specific knockout of 411 leptin receptors had no effect on body weight, basal blood pressure, heart rate and cardiac 441  442  443  444  445  446  447  448  449  450  451  452  453  454  455  456  457  458  459  460  461  462  463  464  465  466  467  468  469  470  471 
